Welcome to the 11th edition of The Future of Swedish & Danish Life Science
– Opportunities in innovation, funding and growth
The annual international partnering-event The Future of Swedish & Danish Life Science started in 2012 and includes a combination of presentations, access to partnering meetings (pre-bookable one-on-one meetings) as well as informal networking. These four core elements of the day run in parallel and ensure that the event is a lively, energetic day designed to impart new knowledge and build new networks.
The purpose of the event is to find out what Swedish and Danish Life Science can learn from each other and to create new important collaborations.
The event attracts 400-500 leading decision makers every year from all over the world. The participants come from the pharma, biotech and medtech sectors, from the academic research and the healtchcare sector as well as from policy makers, regulatory authorities and the financial services sector.
Date: September 7th 2022
Venue: Medicon Village, Lund, Sweden
The event is free of charge for all delegates
- How has Danish and Swedish life science evolved over the past ten years?
- What lies ahead, and how can the life science sector in both countries be
competitive in the coming decade? - What framework conditions, skills and competencies, and type of partnerships
would we need in order to succeed?
Those are some of the questions we will cover during the 11th edition of The Future of Swedish & Danish Life Science.
Program:
| 08:00 | Registration and breakfast |
| 08:30 | Welcome and introduction Samuel Lagercrantz, Editor in chief Life science Sweden |
| 08:35 | Medicon Village – 10 years of co-creation and cooperation to advance life science Petter Hartman, CEO Medicon Village Innovation |
| 08:45 | 25 years of Swedish-Danish life science collaboration Anette Steenberg, CEO Medicon Valley Alliance |
| 08:55 | Nasdaq Bell Ringing Ceremony Håkan Sjögren, Managing Director, Responsible for Listings, Nasdaq Stockholm |
| 09:00 | A Golden Age for Nordic Life Science and how to keep the momentum Søren Nedergaard, COO The Novo Nordisk Foundation |
| 09:20 | Building IP strategies to secure investment Tom Harding, Patent Attorney Potter Clarkson LLP |
| 09:40 | Coffee Break |
| 10:40 | The Nordic Life Science Ecosystem – Rationale for local Venture Funds Tobias Horneman-Thielcke, Founding Partner Eir Ventures |
| 11:00 | How to accelerate Scandinavian life science company funding Johan Kördel, Ph.D. Assoc Prof. Founding |
| 11:20 | Research and Drug development – not the same game Maria Lundberg, CEO, SDS Life Science Anna Törner, Business Director, SDS Life Science |
| 11:40 | Focus on accelerating the growth of the biotech to ensure sustainable future across life science Bassem Saleh, CEO TFS HealthScience |
| 12:00 | Why and how to work with specific areas of high unmet needs such as Womens Health Johanna Roostalu, Women’s Health Program Lead/Senior Scientific Developer, BioInnovation Institute |
| 12:20 | Find scientific expertise anywhere in the world Francesco Ruospo, CBO AcademicLabs |
| 12:25 | Lunch |
| 13:25 | Leading in science and innovating for patients Christina Lloyd, Senior Vice President , Reproductive Medicine & Maternal Health Ferring Pharmaceuticals |
| 13:45 | The furture is now – achieving sustainabillity in the life science business Martina Kvist Reimer, Executive VP and co-owner Red Glead Discovery |
| 14:05 | Cell and gene Therapy – Patience, Potentials, Pitfalls and Patients Eva-Karin Gidlund, Head of Alliance and Innovation Management NorthX Biologics |
| 14:25 | Private-Public partnerships to lead the way in chronic diseases Niels Abel Bonde, CEO Novo Nordisk Scandinavia AB |
| 14:45 | Coffee Break |
| 15:25 | How we enable organ printing Héctor Martínez,, CTO BICO partner of Sound Bioventures |
| 15:45 | Get to know NOME, an elite Nordic Mentoring Program for promising life science startups Peter Birk, Head of Business Development Accelerace Hanna Sjöström, CEO GPX Medical Carl Borrebeack, Professor Department of Immunotechnology |
| 16:00 | How VR can deeply improve operators training and therefore mitigate batch failures in the industry Pascal Lefebvre, Regional Marketing Manager, Pall Corporation |
| 16:20 | Nordic’s Piece in the Global Pharma Innovation Puzzle Duncan Emerton, Executive Director, Custom Intelligence & Analytics (EMEAI), Pharma Intelligence |
| 16:40 | Panel discussion; What to consider before an IPO Anki Malmborg Hager, Business coach, SmiLe Life Science Incubator Hanna Sjöström, CEO, Neola Medical Håkan Sjögren, Managing Director, Responsible for Listings, Nasdaq Stockholm Okee Williams, Corporate advisory, Redeye |
| 16:30 | Summary and conclusion |
| 17:05 | Science After work Arranged by Medicon Village and Miltenyi Biotech featuring interview with Xintela’s CEO Evy Lundgren-åkerlund 17:20 – 17:30 |
More information about the speakers can be found at Speakers & Papers – The Future of Swedish & Danish Life Science 2022 (swedishdanishlifescience.se)
| Organized by | In collaboration with |
|
 |